A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Questcor Pharmaceuticals, Inc.
Information provided by (Responsible Party):
University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT01093157
First received: March 24, 2010
Last updated: January 14, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: February 2013
  Estimated Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)